Literature DB >> 18836688

Modeling the effects of resection, radiation and chemotherapy in glioblastoma.

Jianjun Paul Tian1, Avner Friedman, Jin Wang, E Antonio Chiocca.   

Abstract

The standard treatment for newly diagnosed glioblastoma multiforme is surgical resection followed by radiotherapy and chemotherapy. Most studies on these treatments are retrospective clinical data analysis. To integrate these studies, a mathematical model is developed. The model predicts the survival time of patients who undergo resection, radiation, and chemotherapy with different protocols.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18836688     DOI： 10.1007/s11060-008-9710-6

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


  14 in total

1.  Rapid repopulation in radiotherapy: a debate on mechanism. The phantom of tumor treatment--continually rapid proliferation unmasked.

Authors:  J F Fowler
Journal:  Radiother Oncol       Date:  1991-11       Impact factor: 6.280

Review 2.  Cell production rates in human tissues and tumours and their significance. Part II: clinical data.

Authors:  D A Rew; G D Wilson
Journal:  Eur J Surg Oncol       Date:  2000-06       Impact factor: 4.424

3.  Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses.

Authors:  Giulia Fulci; Laura Breymann; Davide Gianni; Kazuhiko Kurozomi; Sarah S Rhee; Jianhua Yu; Balveen Kaur; David N Louis; Ralph Weissleder; Michael A Caligiuri; E Antonio Chiocca
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-14       Impact factor: 11.205

4.  Hypofractionated radiotherapy for elderly or younger low-performance status glioblastoma patients: outcome and prognostic factors.

Authors:  Eric L Chang; Won Yi; Pamela K Allen; Victor A Levin; Raymond E Sawaya; Moshe H Maor
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-06-01       Impact factor: 7.038

5.  Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias.

Authors:  Walter Stummer; Hanns-Jürgen Reulen; Thomas Meinel; Uwe Pichlmeier; Wiebke Schumacher; Jörg-Christian Tonn; Veit Rohde; Falk Oppel; Bernd Turowski; Christian Woiciechowsky; Kea Franz; Torsten Pietsch
Journal:  Neurosurgery       Date:  2008-03       Impact factor: 4.654

6.  Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis.

Authors:  F K Albert; M Forsting; K Sartor; H P Adams; S Kunze
Journal:  Neurosurgery       Date:  1994-01       Impact factor: 4.654

7.  Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme.

Authors:  Nathan S Floyd; Shiao Y Woo; Bin S Teh; Charlotte Prado; Wei-Yuan Mai; Todd Trask; Philip L Gildenberg; Paul Holoye; Mark E Augspurger; L Steven Carpenter; Hsin H Lu; J Kam Chiu; Walter H Grant; E Brian Butler
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-03-01       Impact factor: 7.038

8.  Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02.

Authors:  M Werner-Wasik; C B Scott; D F Nelson; L E Gaspar; K J Murray; J A Fischbach; J S Nelson; A S Weinstein; W J Curran
Journal:  Cancer       Date:  1996-04-15       Impact factor: 6.860

9.  Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides.

Authors:  J A O'Donoghue; M Bardiès; T E Wheldon
Journal:  J Nucl Med       Date:  1995-10       Impact factor: 10.057

10.  Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

Authors:  Thierry Gorlia; Martin J van den Bent; Monika E Hegi; René O Mirimanoff; Michael Weller; J Gregory Cairncross; Elizabeth Eisenhauer; Karl Belanger; Alba A Brandes; Anouk Allgeier; Denis Lacombe; Roger Stupp
Journal:  Lancet Oncol       Date:  2007-12-21       Impact factor: 41.316
View more
  3 in total

1.  Estimating intratumoral heterogeneity from spatiotemporal data.

Authors:  E M Rutter; H T Banks; K B Flores
Journal:  J Math Biol       Date:  2018-05-08       Impact factor: 2.259

2.  Inter-cellular signaling network reveals a mechanistic transition in tumor microenvironment.

Authors:  Yu Wu; Lana X Garmire; Rong Fan
Journal:  Integr Biol (Camb)       Date:  2012-12       Impact factor: 2.192

3.  Mathematical modeling of PDGF-driven glioma reveals the dynamics of immune cells infiltrating into tumors.

Authors:  Ben Niu; Xianyi Zeng; Tuan Anh Phan; Frank Szulzewsky; Sarah Holte; Eric C Holland; Jianjun Paul Tian
Journal:  Neoplasia       Date:  2020-06-23       Impact factor: 6.218
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.